Hasil Pencarian - Vivek Subbiah

Perbaiki Hasil
  1. 1
    Tissue is Still the Issue for Precision Oncology: A Novel Web-Based Platform for Lesion Selection and Biopsy Specimen Acquisition

    Tissue is Still the Issue for Precision Oncology: A Novel Web-Based Platform for Lesion Selection and Biopsy Specimen Acquisition oleh Vivek Subbiah

    Diterbitkan 2021-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Current and future targeted alpha particle therapies for osteosarcoma: Radium-223, actinium-225, and thorium-227

    Current and future targeted alpha particle therapies for osteosarcoma: Radium-223, actinium-225, and thorium-227 oleh Peter M. Anderson, Vivek Subbiah, Vivek Subbiah, Matteo M. Trucco

    Diterbitkan 2022-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Targeted Therapy of Ewing's Sarcoma

    Targeted Therapy of Ewing's Sarcoma oleh Vivek Subbiah, Pete Anderson

    Diterbitkan 2011-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    COVID-19 Pandemic and Cancer Clinical Trial Pandemonium: Finding the Silver Lining

    COVID-19 Pandemic and Cancer Clinical Trial Pandemonium: Finding the Silver Lining oleh Aakash Desai, Vivek Subbiah

    Diterbitkan 2021-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Precision oncology with selective RET inhibitor selpercatinib in -rearranged cancers

    Precision oncology with selective RET inhibitor selpercatinib in -rearranged cancers oleh Mohamed A. Gouda, Vivek Subbiah

    Diterbitkan 2023-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Key Advances in the Systemic Therapy for Soft tissue Sarcomas: Current Status and Future Directions

    Key Advances in the Systemic Therapy for Soft tissue Sarcomas: Current Status and Future Directions oleh Neelesh Soman, James Hu, Vivek Subbiah, Sant Chawla

    Diterbitkan 2013-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Assessing the Effectiveness of Selective RET Inhibitors in RET-Positive Cancers through Fluorodeoxyglucose Uptake Analysis

    Assessing the Effectiveness of Selective RET Inhibitors in RET-Positive Cancers through Fluorodeoxyglucose Uptake Analysis oleh Kalevi Kairemo, Homer A. Macapinlac, Mohammed Gouda, Vivek Subbiah

    Diterbitkan 2024-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Defining Clinical Response Criteria and Early Response Criteria for Precision Oncology: Current State-of-the-Art and Future Perspectives

    Defining Clinical Response Criteria and Early Response Criteria for Precision Oncology: Current State-of-the-Art and Future Perspectives oleh Vivek Subbiah, Hubert H. Chuang, Dhiraj Gambhire, Kalevi Kairemo

    Diterbitkan 2017-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    An Assessment of Early Response to Targeted Therapy via Molecular Imaging: A Pilot Study of 3′-deoxy-3′[(18)F]-Fluorothymidine Positron Emission Tomography 18F-FLT PET/CT in Prostate Adenocarcinoma

    An Assessment of Early Response to Targeted Therapy via Molecular Imaging: A Pilot Study of 3′-deoxy-3′[(18)F]-Fluorothymidine Positron Emission Tomography 18F-FLT PET/CT in Prosta... oleh Kalevi Kairemo, Gregory C. Ravizzini, Homer A. Macapinlac, Vivek Subbiah

    Diterbitkan 2017-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Beyond KRAS: Practical Molecular Targets in Pancreatic Adenocarcinoma

    Beyond KRAS: Practical Molecular Targets in Pancreatic Adenocarcinoma oleh Albert Grinshpun, Yonaton Zarbiv, Jason Roszik, Vivek Subbiah, Ayala Hubert

    Diterbitkan 2019-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Early Response Assessment to Targeted Therapy Using 3′-deoxy-3′[(18)F]-Fluorothymidine (<sup>18</sup>F-FLT) PET/CT in Lung Cancer

    Early Response Assessment to Targeted Therapy Using 3′-deoxy-3′[(18)F]-Fluorothymidine (<sup>18</sup>F-FLT) PET/CT in Lung Cancer oleh Kalevi Kairemo, Elmer B. Santos, Homer A. Macapinlac, Vivek Subbiah

    Diterbitkan 2020-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    For what it’s worth: the complex area of medicine value assessment

    For what it’s worth: the complex area of medicine value assessment oleh Sreeram V Ramagopalan, Catrin Treharne, Jonathan Pearson-Stuttard, Vivek Subbiah

    Diterbitkan 2023-01-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    On target methods to induce abscopal phenomenon for Off‐Target effects: From happenstance to happenings

    On target methods to induce abscopal phenomenon for Off‐Target effects: From happenstance to happenings oleh Blessie Elizabeth Nelson, Jacob J. Adashek, Steven H. Lin, Vivek Subbiah

    Diterbitkan 2023-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    The value of innovation: association between improvements in survival of advanced and metastatic non-small cell lung cancer and targeted and immunotherapy

    The value of innovation: association between improvements in survival of advanced and metastatic non-small cell lung cancer and targeted and immunotherapy oleh Sreeram Ramagopalan, Thomas P. Leahy, Joshua Ray, Samantha Wilkinson, Cormac Sammon, Vivek Subbiah

    Diterbitkan 2021-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    The L730V/I RET roof mutations display different activities toward pralsetinib and selpercatinib

    The L730V/I RET roof mutations display different activities toward pralsetinib and selpercatinib oleh Tao Shen, Xueqing Hu, Xuan Liu, Vivek Subbiah, Blaine H. M. Mooers, Jie Wu

    Diterbitkan 2021-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Drugging KRAS: current perspectives and state-of-art review

    Drugging KRAS: current perspectives and state-of-art review oleh Kaushal Parikh, Giuseppe Banna, Stephen V. Liu, Alex Friedlaender, Aakash Desai, Vivek Subbiah, Alfredo Addeo

    Diterbitkan 2022-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Quantitative bias analysis for external control arms using real-world data in clinical trials: a primer for clinical researchers

    Quantitative bias analysis for external control arms using real-world data in clinical trials: a primer for clinical researchers oleh Kristian Thorlund, Stephen Duffield, Sanjay Popat, Sreeram Ramagopalan, Alind Gupta, Grace Hsu, Paul Arora, Vivek Subbiah

    Diterbitkan 2024-03-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Challenges in the care of patients with RET-altered thyroid cancer: a multicountry mixed-methods study

    Challenges in the care of patients with RET-altered thyroid cancer: a multicountry mixed-methods study oleh Suzanne Murray, Vivek Subbiah, Steven I. Sherman, Sophie Péloquin, Anthony Sireci, Christian Grohé, Patrick Bubach, Patrice Lazure

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    Development of sodium fluoride PET response criteria for solid tumours (NAFCIST) in a clinical trial of radium-223 in osteosarcoma: from RECIST to PERCIST to NAFCIST

    Development of sodium fluoride PET response criteria for solid tumours (NAFCIST) in a clinical trial of radium-223 in osteosarcoma: from RECIST to PERCIST to NAFCIST oleh Kalevi Kairemo, Vivek Subbiah, Eric M Rohren, Pete M Anderson, Gregory Ravizzini, Arvind Rao, Homer A Macapinlac

    Diterbitkan 2019-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Osteosarcoma with cell-cycle and fibroblast growth factor genomic alterations: case report of Molecular Tumor Board combination strategy resulting in long-term exceptional response

    Osteosarcoma with cell-cycle and fibroblast growth factor genomic alterations: case report of Molecular Tumor Board combination strategy resulting in long-term exceptional response oleh Hanna E. Persha, Shumei Kato, Pradip De, Jacob J. Adashek, Jason K. Sicklick, Vivek Subbiah, Razelle Kurzrock

    Diterbitkan 2022-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: